Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | UBE2E3 |
| Upstream (Parents) |
|---|
| (<<) CSNK1A1 → UBE2E3 |
| (<<) DEPDC7 → UBE2E3 |
| (<<) E2F6 → UBE2E3 |
| (<<) FAM48A → UBE2E3 |
| (<<) GAD1 → UBE2E3 |
| (<<) GLRX → UBE2E3 |
| (<<) GNG5 → UBE2E3 |
| (<<) GSK3B → UBE2E3 |
| (<<) ITPR1 → UBE2E3 |
| (<<) ITPR2 → UBE2E3 |
| (<<) KLHL7 → UBE2E3 |
| (<<) LRP8 → UBE2E3 |
| (<<) MAP6D1 → UBE2E3 |
| (<<) MRAS → UBE2E3 |
| (<<) PLCD4 → UBE2E3 |
| (<<) RHOQ → UBE2E3 |
| (<<) SPR → UBE2E3 |
| (<<) STK40 → UBE2E3 |
| (<<) TCF7L1 → UBE2E3 |
| (<<) TUBA1A → UBE2E3 |
| Downstream (Children) |
|---|
| UBE2E3 → ADCY9 (>>) |
| UBE2E3 → BCAR3 (>>) |
| UBE2E3 → CDC42 (>>) |
| UBE2E3 → CREB5 (>>) |
| UBE2E3 → IL20 (>>) |
| UBE2E3 → ITGA2 (>>) |
| UBE2E3 → KLF11 (>>) |
| UBE2E3 → LARP6 (>>) |
| UBE2E3 → MAP3K5 (>>) |
| UBE2E3 → NRAS (>>) |
| UBE2E3 → PODXL (>>) |
| UBE2E3 → RBP1 (>>) |
| UBE2E3 → RGS20 (>>) |
| UBE2E3 → RRAS2 (>>) |
| UBE2E3 → WNT3 (>>) |
